A new therapeutic agent for moderate to severe atopic dermatitis: abrocitinib

doi:10.3969/j.issn.1672-3384.2022.11.003

PDF(407 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (11) : 12-16. DOI: 10.3969/j.issn.1672-3384.2022.11.003

Comment of New Drug

A new therapeutic agent for moderate to severe atopic dermatitis: abrocitinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(11): 12-16 https://doi.org/10.3969/j.issn.1672-3384.2022.11.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(407 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-08-20	2022-11-29
Issue Date
2022-11-29

Please choose a citation manager

Content to export